|Other Names||Vitamin K-dependent protein C, Anticoagulant protein C, Autoprothrombin IIA, Blood coagulation factor XIV, Vitamin K-dependent protein C light chain, Vitamin K-dependent protein C heavy chain, Activation peptide, PROC|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13543c was selected from the Center region of PROC. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Protein C is a vitamin K-dependent serine protease that regulates blood coagulation by inactivating factors Va and VIIIa in the presence of calcium ions and phospholipids (PubMed:25618265). Exerts a protective effect on the endothelial cell barrier function (PubMed:25651845).|
|Cellular Location||Secreted. Golgi apparatus. Endoplasmic reticulum|
|Tissue Location||Plasma; synthesized in the liver.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a vitamin K-dependent plasmaglycoprotein. The encoded protein is cleaved to its activated formby the thrombin-thrombomodulin complex. This activated formcontains a serine protease domain and functions in degradation ofthe activated forms of coagulation factors V and VIII. Mutations inthis gene have been associated with thrombophilia due to protein Cdeficiency, neonatal purpura fulminans, and recurrent venousthrombosis.
Tang, W., et al. Blood (2010) In press :Agapkina, Iu.V., et al. Mol. Biol. (Mosk.) 44(4):613-619(2010)Witt, I., et al. Blood Coagul. Fibrinolysis 5(4):651-653(1994)Zhang, L., et al. Blood 80(4):942-952(1992)Grundy, C.B., et al. Hum. Genet. 89(6):683-684(1992)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.